KRAS and carcinoma: We performed in vitro experiments, confirming the effectiveness of MEK inhibitor on the <i>KRAS</i>-mutated OVCAR-5 cell line, and the constitutively activation of MAPK cascade in <i>RAS</i>-mutated carcinoma.